modafinil has been researched along with clomipramine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dauvilliers, Y; Tafti, M | 1 |
| Camblor, E; Fernández, R; Janeiro, M; Núñez, D | 1 |
| Cavanna, AE; Rickards, H; Tarrant, N | 1 |
| Santamaria-Cano, J | 1 |
| Panda, S | 1 |
3 review(s) available for modafinil and clomipramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Molecular genetics and treatment of narcolepsy.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Catechol O-Methyltransferase; Central Nervous System Stimulants; Clomipramine; Genetic Predisposition to Disease; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Modafinil; Molecular Biology; Narcolepsy; Neuropeptides; Orexin Receptors; Orexins; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Sodium Oxybate | 2006 |
[Diagnostic and therapeutic update in narcolepsy].
Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Child; Clomipramine; Cyclohexanols; Delayed Diagnosis; Disease Models, Animal; Dogs; Genetic Predisposition to Disease; Histamine Agonists; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Hypothalamus; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Receptors, Antigen, T-Cell; Sodium Oxybate; Venlafaxine Hydrochloride | 2012 |
5 other study(ies) available for modafinil and clomipramine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Narcolepsy and anesthesia].
Topics: Analgesia, Epidural; Anesthesia, Intravenous; Antiemetics; Benzhydryl Compounds; Chemical and Drug Induced Liver Injury; Clomipramine; Contraindications; Humans; Hypnotics and Sedatives; Intracellular Signaling Peptides and Proteins; Intraoperative Complications; Kidney Pelvis; Modafinil; Narcolepsy; Neuropeptides; Ondansetron; Orexins; Pain, Postoperative; Piperidines; Preanesthetic Medication; Propofol; Remifentanil; Ureteral Obstruction | 2007 |
Pathological gambling associated with modafinil.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Clomipramine; Disruptive, Impulse Control, and Conduct Disorders; Gambling; Humans; Male; Modafinil; Narcolepsy; Treatment Outcome | 2010 |
Status cataplecticus as initial presentation of late onset narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Clomipramine; Diagnosis, Differential; Electroencephalography; Follow-Up Studies; Humans; Male; Middle Aged; Modafinil; Narcolepsy; Polysomnography; Treatment Outcome; Wakefulness-Promoting Agents | 2014 |